Automated And Closed Cell Therapy Processing Systems Market Size, Report 2021-2030
The global Automated And Closed Cell Therapy Processing Systems market size is expected to be worth around US$ 6.94 billion by 2030, according to a new report by Vision Research Reports.
The global Automated And Closed Cell Therapy Processing Systems market size was valued at US$ 715.0 million in 2020 and is anticipated to grow at a CAGR of 22.7% during forecast period 2021 to 2030.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 6.94 Billion by 2030 |
| Growth Rate | CAGR of 22.7% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Workflow, Type, Scale |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | MiltenyiBiotec; Lonza; Fresenius Kabi; Cytiva (Danaher Corp.); BioSpherix, Ltd.; Terumo Corporation; Sartorius AG; ThermoGenesis Holdings, Inc.; Cellares, Inc.; Thermo Fisher Scientific, Inc. |
Growth Factors
The growing popularity of regenerative medicines & cell therapies coupled with a range of benefits offered by automation technologies for the development of these therapies is expected to propel the market growth. In addition, the growing integration of software technologies and advanced therapy development processes is also projected to boost the market. Furthermore, rising investments by bio manufacturers for the development of cellular therapy products through rounds of series funding are anticipated to offer lucrative opportunities to or the market.
The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.
By Workflow Analysis
The expansion segment accounted for the largest revenue share of more than 35% in 2020. The growth is majorly attributed to the presence of a substantial number of products offered under this segment.
separation workflow is estimated to register the fastest CAGR during the forecast period. The cell separation process is carried out across various cellular experiments, such as molecular analysis, cellular genetic modification, production of hybridomas, and other cell research & analysis-related applications.
A growing number of research activities for these applications in academic universities and other research settings is anticipated to accelerate the segment growth. Apart from expansion and separation, the workflow segment comprises apheresis, fill-finish, cryopreservation, and others.
By Type Analysis
The non-stem cell therapy segment captured the maximum revenue share of over 61% in 2020 and is anticipated to register the fastest CAGR during the forecast period. An increasing number of product launches for non-stem cell therapy applications is expected to drive the segment growth.
Companies are extensively engaging in partnerships and collaboration with an aim to develop new regenerative medicines for the treatment of chronic conditions. Such research projects majorly focus on applications of non-stem cells, consequently driving the non-stem cell therapy segment growth.
The stem cell therapy segment is anticipated to witness a significant growth rate during the forecast period. Increasing awareness about therapeutic benefits offered by stem cell therapies and rising research activities.
By Scale Analysis
The pre-commercial/R&D scale segment dominated the global market in 2020 with a revenue share of more than 72%.At present, the market is relatively niche due to a limited number of products. Moreover, the majority of the companies are introducing their products only for research purposes.
the adoption of automated systems by research institutes due to the growing number of clinical trials for cell therapies is also projected to accelerate segment growth. The laboratories and research institutes are witnessing a range of benefits due to the adoption of automated systems.
The commercial-scale segment is expected to register the fastest CAGR from 2021 to 2028. The increasing prevalence of chronic conditions, such as cancer, is encouraging companies to develop enhanced cell-therapy-based therapeutic platforms.
By Regional Analysis
North America accounted for the largest revenue share of over 45.5%in 2020. This high share was majorly attributed to the increased technological adoption for cell therapy processing and emphasis on high precision & production throughput.
Growing investments by market players as well as research institutes are also expected to play a vital role in the region’s growth. Growing investments by market players as well as research institutes are also expected to play a vital role in the region’s growth.
Over the recent year, a series of fully automated platforms were introduced across European countries, which is capable of supporting the bioprocess workflows from start to end.
Key Players
MiltenyiBiotec
Lonza
Fresenius Kabi
Cytiva (Danaher Corp.)
BioSpherix, Ltd.
Terumo Corporation
Sartorius AG
ThermoGenesis Holdings, Inc.
Cellares Inc.
Thermo Fisher Scientific, Inc.
Market Segmentation
By Workflow
Separation
Expansion
Apheresis
Fill- Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/R&D Scale
Commercial Scale
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
UAE
The Automated And Closed Cell Therapy Processing Systems market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Automated And Closed Cell Therapy Processing Systems market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Automated And Closed Cell Therapy Processing Systems market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Automated And Closed Cell Therapy Processing Systems market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Automated And Closed Cell Therapy Processing Systems market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Automated And Closed Cell Therapy Processing Systems capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Automated And Closed Cell Therapy Processing Systems by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Automated And Closed Cell Therapy Processing Systems market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Automated And Closed Cell Therapy Processing Systems market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Automated And Closed Cell Therapy Processing Systems market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Automated And Closed Cell Therapy Processing Systems industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Automated And Closed Cell Therapy Processing Systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Automated And Closed Cell Therapy Processing Systems market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Automated And Closed Cell Therapy Processing Systems market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Automated And Closed Cell Therapy Processing Systems market. These factors have benefited the growth of the global market for Automated And Closed Cell Therapy Processing Systems. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Automated And Closed Cell Therapy Processing Systems. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Automated And Closed Cell Therapy Processing Systems are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers